Poland’s Simpact Ventures invests in Verdant Nature, a biotech company

Polish investment fund Simpact Ventures has made an investment in Verdant Nature, a biotech company improving the ways the body can absorb supplements. This is the thirtieth company in the fund’s portfolio, My Company Polska reports.

• Verdant Nature is a Polish-American biotechnology company transforming the $160 billion global supplement market with its innovative technology — BioSNEDS. The tech revolutionizes how human bodies absorb nutrients in dietary supplements, ensuring significantly greater absorption of active ingredients and a substantial boost in supplement effectiveness.
• The startup is composed of an international team of experts with extensive industry experience. The company has its own production plant, laboratory, and R&D center.
• The fresh funds will fuel Verdant Nature’s international expansion and R&D efforts, addressing global health challenges. 

About Simpact Ventures

• This strategic investment enhances Simpact Ventures’ impact in the dynamic health sector. The firm manages funds of over a €30 million. With its recent Simpact 2.0 backed by the European Investment Fund, the firm is looking for the best impact-driven startups in CEE and wider.